Current treatment for intermediate-stage hepatocellular carcinoma
10.3760/cma.j.issn.1673-9752.2016.04.020
- VernacularTitle:中期肝癌的治疗现状
- Author:
Wenxin WEI
;
Zhengqing LEI
;
Kui WANG
;
Feng SHEN
- Publication Type:Journal Article
- Keywords:
Liver neoplasms;
Intermediate stage;
Substaging;
Therapy
- From:
Chinese Journal of Digestive Surgery
2016;15(4):407-410
- CountryChina
- Language:Chinese
-
Abstract:
Staging of hepatocellular carcinoma (HCC) need to consider tumor factors and functional status of liver,which is different from other solid tumors.Now there are many clinical staging and prognosis systems of HCC.Intermediate stage HCC is commonly occurred at disease diagnosis,with varied clinicopathological charactertics,therapeutic options and survival outcomes of patients.In this review,the definition,current therapeutic strategies,substaging model of intermediatestage HCC and the efficacy of liver resection for patients of intermediate-stage HCC are discussed for further improving feasibility of individualized surgical therapy.
